by TractManager | Dec 29, 2017 | Precision Therapy Assessment
Health Problem: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 6% to 20% of women of reproductive age. It is characterized by oligoovulation (menstrual irregularity), hyperandrogenism (increased testosterone levels), and polycystic ovaries....
by TractManager | Dec 29, 2017 | Health Technology Assessment
Health Problem: Injury to the anterior cruciate ligament (ACL) occurs frequently among high-intensity athletes and treatment often requires surgical intervention due to the limited intrinsic capacity of the ligament for spontaneous healing. ACL injuries occur most...
by TractManager | Dec 27, 2017 | Precision Therapy Assessment
Health Problem: Short bowel syndrome (SBS) is a rare malabsorptive condition in which the bowel is anatomically or functionally inadequate to meet absorptive nutritional needs. The goal of SBS therapy is to optimize enteral autonomy and reductions in parenteral...
by TractManager | Dec 19, 2017 | Emerging Technology Report
Yescarta (axicabtagene ciloleucel) is an autologous chimeric antigen receptor (CAR) T-cell therapy. It is produced by adapting the patient’s own immune cells to recognize and attack specifically targeted cancer cells. Yescarta is FDA-approved to treat adult patients...
Recent Comments